Brinzolamide
- Generic Name
- Brinzolamide
- Brand Names
- Azarga, Azopt, Simbrinza
- Drug Type
- Small Molecule
- Chemical Formula
- C12H21N3O5S3
- CAS Number
- 138890-62-7
- Unique Ingredient Identifier
- 9451Z89515
- Background
Brinzolamide is a highly specific, non-competitive, reversible carbonic anhydrase II (CA-II) inhibitor indicated to reduce ocular pressure in patients with ocular hypertension or open-angle glaucoma. Although the exact pathophysiology of glaucoma is still unknown, one of the main hallmarks of this disease is vascular dysregulation and abnormalities. The resu...
- Indication
Brinzolamide, either as a standalone agent or in combination with brimonidine, is approved by the FDA for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. Brinzolamide is also approved in Europe to be used in combination with timolol to treat the same conditions.
- Associated Conditions
- Increased Intra Ocular Pressure (IOP)
- Associated Therapies
- -
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.